MedTrace Logo

Mapping Diabetes in Quebec: Validating Medico-administrative Algorithms for Type 1 Diabetes, Type 2 Diabetes and LADA

NCT06573905 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 17271

Last updated 2025-01-01

No results posted yet for this study

Summary

The goal of this observational study is to validate medico-administrative algorithms that classify diabetes phenotypes (Type 1, Type 2, and Latent Autoimmune Diabetes in Adults - LADA) in a population-based cohort in Quebec, including children, adolescents, and young adults up to 40 years old with diagnosed diabetes. The main questions it aims to answer are:

Can these algorithms accurately distinguish between Type 1, Type 2, and LADA across different age groups? What is the prevalence and incidence of each diabetes phenotype in Quebec? Participants will have their medical and administrative data analyzed, including data on medication usage and healthcare visits, to validate the accuracy of the algorithms. The study will involve comparing these algorithm-based classifications with clinical diagnoses or self-reported data to ensure reliability.

Conditions

  • Diabetes Mellitus, Type 1
  • Diabete Type 2
  • Diabetes;Adult Onset
  • Diabetes, Autoimmune

Interventions

OTHER

no intervention

no intervention. this is observational study.

Sponsors & Collaborators

  • McGill University

    collaborator OTHER

  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal

    collaborator OTHER

  • University Hospital, Angers

    collaborator OTHER_GOV

  • Universite du Quebec en Outaouais

    lead OTHER

Principal Investigators

  • philippe C corsenac, Ph.D · UQO

Eligibility

Min Age
1 Year
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2025-06-30
Completion
2025-06-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06573905 on ClinicalTrials.gov